# FDA Inspection 1281296 - Biologica Technologies, LLC - September 04, 2025

Source: https://www.keypedia.com/records/fda_inspections/biologica-technologies-llc/11315e62-603c-4654-a977-8e16db174a44
Source feed: FDA_Inspections

> FDA Inspection 1281296 for Biologica Technologies, LLC on September 04, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1281296
- Company Name: Biologica Technologies, LLC
- Inspection Date: 2025-09-04
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1281296 - 2025-09-04](https://www.keypedia.com/records/fda_inspections/biologica-technologies-llc/cb53003e-6875-4b23-b511-d69bc2c0afed)
- [FDA Inspection 1014814 - 2017-04-06](https://www.keypedia.com/records/fda_inspections/biologica-technologies-llc/54faefad-d53d-4882-aa23-f1f2a064b789)

Company: https://www.keypedia.com/companies/biologica-technologies-llc/18f14014-f470-4cd4-84b4-abec7a9d0c1a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d